Technical Excellence and Clinical Innovation: Jiangxi Provincial People's Hospital Successfully Performs Atrial Fibrillation Pulsed Field Ablation Using AccuPulse® Adjustable Loop Catheter by AcoMed

Following the success of being one of the first centers in China to carry out the initial application,Professor Lai Hengli, Dean of the Cardiovascular Hospital of Jiangxi Provincial People's Hospital, Professor Tao Yu, Deputy Chief of Cardiology, and their teamSuccessfully Completed Another Case Using AccuPulse^®Single-use Cardiac Pulsed Field Ablation Catheter and AccuBlator^®Atrial Fibrillation Ablation Surgery with Cardiac Pulsed Field Ablation System.

Different from the first exploratory application, the surgical team was more proficient and efficient this time based on prior experience. The patient was a 61-year-old male, and according to preoperative examinations, the surgeon selected the AccuPulse 20-25mm adjustable loop cardiac pulse field ablation catheter. The entire procedure maintained the inherent high safety of PFA technology, with a positive patient experience. The total duration of the surgery was only 91 minutes, smooth and highly efficient, once again demonstrating the outstanding value of the AccuPulse Cardiac Pulse Field Ablation System in clinical practice.

Schematic Diagram of Substrate Mapping Before and After Ablation

This surgery successfully completed venous puncture and atrial septal puncture, establishing a stable left atrial interventional access. Subsequently, a pulsed field ablation (PFA) catheter was inserted to complete the three-dimensional modeling of the left atrium and electrophysiological substrate mapping. The mapping results indicated the presence of a substrate-deficient area at the top of the patient's atrium.

Professor Lai Hengli gave a positive evaluation of the clinical trial of the adjustable loop catheter this time. The continuous clinical trials indirectly reflect her recognition of the core advantages of AccuPulse's PFA product. The operator fully affirmed the significant advantages of the catheter in terms of operational feel and overall controllability, and from a clinical practical perspective, pointed out that when dealing with complex substrates or ensuring linear continuous ablation, it could be considered to use the loop catheter in conjunction with point ablation catheters to form a more comprehensive treatment plan.

Flexible Adaptation, Precise Adherence:Its unique 7.5F adjustable loop diameter design can flexibly match the pulmonary vein anatomy of different patients, achieving personalized adaptation and significantly enhancing the adaptability and safety of the procedure.

Intelligent docking, real-time feedback:The system is equipped with AccuPulse's independently developed impedance contact prompting technology, which can monitor the catheter-tissue contact quality in real time, clearly indicate the contact status, assist operators in achieving stable and reliable catheter manipulation, and provide a solid guarantee for precise ablation.

Efficient Integration, Streamlined Processes:The circular catheter integrates mapping, modeling, and ablation functions, rapidly constructing a three-dimensional electroanatomical model of the heart during surgery, precisely locating lesions, and significantly reducing the reliance on additional high-density mapping catheters in traditional surgeries. This not only decreases surgical complexity but also saves on consumable costs, providing atrial fibrillation patients with a safer, more effective, and less invasive treatment option.

Safer:7.5F Ultra-Fine Catheter, Reducing Tissue Damage

More Stable:Smart Snap Tips for More Precise Operation

More flexible:Adjustable loop diameter (15-20mm or 20-25mm) to meet different clinical choices.

AccuPulse Medical Technology Co., Ltd. has received approval for its disposable cardiac pulsed field ablation catheter, which overcomes the challenges of stability and anatomical adaptability in PFA ablation catheters, providing a precise and reliable solution for pulmonary vein isolation (PVI). The unique 7.5F adjustable loop diameter design of the AccuPulse cardiac pulsed field ablation catheter flexibly adapts to different anatomical structures of the pulmonary veins. Intelligent contact indication and flexible electrode selection give operators complete control, enabling precise pulsed field ablation!

AccuPulse is an innovative enterprise focused on the research, development, and industrialization of advanced technologies in the field of cardiac electrophysiology. The company’s core team possesses a deep background in electrophysiological technology and extensive experience in the industrialization of medical devices, consistently striving to provide safer, more efficient, and more convenient treatment options for patients with arrhythmias such as atrial fibrillation.

This time, AccuPulse^®Single-use Cardiac Pulsed Field Ablation Catheter and AccuBlator^®The successful application of the cardiac pulsed electric field ablation system at Jiangxi Provincial People's Hospital marks a milestone advancement for AccuPulse in the field of innovative electrophysiological treatment technology.

The Department of Cardiology at Jiangxi Provincial People's Hospital originated from the Cardiology Specialty Group established in 1954. By the early 1980s, it had evolved into an independent specialty with a primary focus on interventional surgical treatment, being the first discipline in the province to carry out cardiovascular interventional techniques. In the field of cardiovascular intervention, particularly in complex and high-risk lesion interventions and the interventional treatment of complicated arrhythmias, the department is recognized as having a leading level of expertise both nationally and internationally. The center leads the province in terms of surgical volume and medical service quality. Currently, the Department of Cardiology at Jiangxi Provincial People's Hospital serves as the Cardiovascular Disease Interventional Diagnosis and Treatment Center of Jiangxi Province and is a key provincial interventional discipline. In 2001, it was designated as the "Jiangxi Base of the Chinese Medical Association Cardiovascular Interventional Therapy Training Center"; in 2008, it was awarded the "Congenital Heart Disease Training Base for Cardiovascular Interventional Diagnosis and Treatment Technology" by the Ministry of Health, as well as the "Arrhythmia Intervention Training Base for Cardiovascular Interventional Diagnosis and Treatment Technology." In 2009, the Ministry of Health granted it the title of "Coronary Heart Disease Interventional Treatment Quality Control Center," and in November 2018, it was recognized by the Chinese Medical Association as the "China Atrial Fibrillation Center" and the "China Atrial Fibrillation Center Demonstration Base."

Professor, Chief Physician, Master's Supervisor, President of Jiangxi Provincial Cardiovascular Hospital. Member of the Third Committee of the Chinese Heart Rhythm Society under the Chinese Medical Doctor Association, Member of the Cardiac Critical Care Professional Committee under the Chinese Medical Doctor Association, Standing Committee Member of the Geriatric Cardiovascular Branch under the Chinese Research Hospital Association for Geriatric Health Care Medicine, Incoming Chairman of the Cardiac Valve Branch of the Jiangxi Medical Association, Chairman of the Electrophysiology Professional Committee of the Jiangxi Interventional Cardiology Society, Secretary-General of the Jiangxi Interventional Cardiology Society, Vice President of the First Committee of the Cardiovascular Physicians Branch under the Jiangxi Medical Doctor Association, Member of the Metabolic Cardiovascular Disease Group of the Eleventh Committee of the Chinese Society of Cardiology, Arrhythmia and Left Atrial Appendage Occlusion Mentor at the Cardiovascular Interventional Diagnosis and Treatment Technology Base of the Ministry of Health, Deputy Editor-in-Chief of the Chinese edition of the European Heart Journal, and Editorial Board Member of the Second Edition of the Chinese Journal of Heart and Heart Rhythm (Electronic Version).

Has been engaged in the diagnosis and treatment of cardiovascular diseases (such as hypertension, coronary heart disease, heart failure, arrhythmia, etc.). In 2012, went to St. George Medical Center in Germany to study interventional treatment for complex arrhythmias. Particularly skilled in the clinical and interventional treatment of various arrhythmias, routinely performs advanced techniques such as radiofrequency ablation for complex arrhythmias (atrial fibrillation, atrial tachycardia, atrial flutter, premature ventricular contractions, ventricular tachycardia), hypertrophic obstructive cardiomyopathy, left atrial appendage closure, and various pacemaker implantation procedures. Especially proficient in radiofrequency ablation treatment for different types of atrial fibrillation, customizing individualized treatment plans based on each patient’s condition. One of the operators with the highest number of arrhythmia surgeries in Jiangxi Province, awarded the "Outstanding Electrophysiology Physician Award in China" by the Asian Heart Rhythm Society in 2024.

Actively participate in academic promotion activities in China, and have organized national and provincial arrhythmia continuing education training courses multiple times, promoting pacing and ablation technologies to cities such as Pingxiang, Yichun, Xinyu, Ganzhou, and Jingdezhen. Pioneered the first cases of dual-chamber and three-dimensional radiofrequency ablation and pacing technologies in many prefecture-level hospitals. As the corresponding author, published over 60 academic papers in domestic and international journals, including 16 SCI articles. Led three sub-center research projects under the National Key Technology Support Program, one project from the Provincial Department of Science and Technology, five projects from the Provincial Health Commission, and served as the principal investigator for eight clinical studies on drugs and medical devices at the sub-center.

Doctor of Medicine, Associate Chief Physician, Deputy Director of the Seventh Department of Cardiology at the Cardiovascular Hospital of Jiangxi Provincial People's Hospital. Areas of expertise: interventional treatment for arrhythmias, performing over 300 radiofrequency ablation surgeries annually for various types of tachycardia, including complex arrhythmias, with a total of more than 2,000 surgeries. Member of the Youth Committee of the Chinese Society of Integrated Traditional and Western Medicine, Deputy Chairman of the Jiangxi Medical Association's Branch of Electrophysiology and Pacing, Standing Committee Member of the Jiangxi Society of Cardiac Intervention’s Electrophysiology Society, Standing Committee Member of the Jiangxi Traditional Chinese Medicine Society’s Cardiovascular Disease Professional Committee, and Arrhythmia Mentor for the Cardiovascular Disease Intervention Training of the Chinese Medical Doctor Association. Principal investigator of one Natural Science Foundation of Jiangxi Province project and two Science and Technology Fund projects of the Jiangxi Provincial Health Commission. Key participant in three National Natural Science Foundation projects, with over 10 papers published as the first or corresponding author, including five SCI papers.